|
| Status |
Public on Jun 14, 2024 |
| Title |
FOXC1 in triple negative breast cancer [ChIP-seq] |
| Organism |
Homo sapiens |
| Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
To investigate FOXC1 chromatin binding, and the effect of FOXC1 CRISPR knockout in triple negative breast cancer cell lines MDA-MB-231, MDA-MB-468, Hs578t, and Bt-549.
|
| |
|
| Overall design |
We performed RNA-seq on WT and FOXC1 KO lines, and ChIP-seq for FOXC1 on WT cell lines.
|
| |
|
| Contributor(s) |
Ramachandran R, Woods L, Ali F |
| Citation(s) |
39171293 |
| |
| Submission date |
Sep 21, 2022 |
| Last update date |
Sep 26, 2024 |
| Contact name |
Fahad Ali |
| E-mail(s) |
fahad.ali@mbru.ac.ae
|
| Organization name |
Mohammed Bin Rashid University of Medicine and Health Sciences
|
| Street address |
Bldg 14, Dubai Healthcare City
|
| City |
Dubai |
| ZIP/Postal code |
505055 |
| Country |
United Arab Emirates |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (20)
|
|
| This SubSeries is part of SuperSeries: |
| GSE213841 |
FOXC1 in triple negative breast cancer |
|
| Relations |
| BioProject |
PRJNA882756 |
Less...
More...